Top 10 Early Analyst Upgrades & Downgrades (FUL, OZM, REP, TOL, DOV, EMR, GA, GSK, MEDX, RDS-A)

Investing

Published: November 14, 2008 7:26 am

Last Updated: April 28, 2020 7:53 am

Money_stack_pic These are ten of the top pre-market early bird upgrades and downgrades we are seeing from analysts this Friday morning:

H.B. Fuller (NYSE: FUL) Raised to Overweight at JPMorgan.
Och-Ziff Capital (NYSE: OZM) Started as Buy at Jefferies.
Repsol YPF (NYSE: REP) Raised to Buy from Hold at ING; Raised to Hold from Sell at Soc-Gen.
Toll Brothers (NYSE: TOL) Started as Outperform at KBW.
Dover (NYSE: DOV) Cut to Underweight at JPMorgan.
Emerson Electric (NYSE: EMR) Cut to Underweight at JPMorgan.
Giant Interactive (NYSE: GA) Cut to Perform at Oppenheimer.
GlaxoSmithkline (NYSE: GSK) Cut to Neutral from Buy at UBS.
Medarex (NASDAQ: MEDX) Started as Sell at Merriman Curhan Ford.
Royal Dutch Shell (NYSE: RDS-A) Cut to Hold from Buy at ING.

Jon C. Ogg
November 14, 2008

Travel Cards Are Getting Too Good To Ignore

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.